results
Last reviewed 01/2018
Of the 47 patients who completed the trial there were significant improvements with lisinopril for the following endpoints:
- hours with headache reduced by 20%
- days with headache reduced by 17%
- days with migraine reduced by 21%
- headache severity index reduced by 20%
The same endpoints were better for lisinopril when the data was analysed on an intention to treat basis.